Benefits seen for body composition, lipid profile, and glucose regulation
Read More »HealthDay.com
Exposure to Food Additive Emulsifiers Linked to Risk for Type 2 Diabetes
Direct associations found between exposures to various food additive emulsifiers and risk for type 2 diabetes
Read More »SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease
Benefits include lower risk for dialysis, hospitalization for myocardial infarction, heart failure, acute kidney injury, and diabetic ketoacidosis
Read More »Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
Intensive therapy reduces excess risk for CVD events associated with earlier diagnosis in women, but not men
Read More »Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Read More »Cabozantinib Promising for Advanced Adrenocortical Carcinoma
Promising efficacy seen with a manageable safety profile in phase 2 study involving 18 patients
Read More »New School Lunch Rules Target Added Sugars, Salt
By Robin Foster HealthDay ReporterTHURSDAY, April 25, 2024 (HealthDay News) — School lunches will soon contain less added sugar and salt under new nutrition standards announced by the U.S. Department of Agriculture on Wednesday.âWe all share the goal of helping children reach their full potential,â Agriculture Secretary Tom Vilsack said …
Read More »GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use
Read More »New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.Thatâs because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the …
Read More »ACP: Time-Restricted Eating May Not Aid Weight Loss, Glycemic Measures
Findings seen in trial where calories were held constant for both groups
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.